Euro vs US Dollar

Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.

Registrieren

AMRX Amneal Pharmaceuticals Holding Co

5,87

0,00 (0,00%)

06 Mai 2024 - Geschlossen

Verzögert um 15 Minuten

Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]

Amneal Pharmaceuticals (NYSE:AMRX)
Historical Stock Chart
Von Apr 2024 bis Mai 2024

Click Here for more Amneal Pharmaceuticals Charts.

Amneal Pharmaceuticals (NYSE:AMRX)
Historical Stock Chart
Von Mai 2023 bis Mai 2024

Click Here for more Amneal Pharmaceuticals Charts.

News Amneal Pharmaceuticals Holding Co

Form 8-K - Current report
Freitag 3 Mai 2024 (3 Tage vor) • Edgar (US Regulatory)

Amneal Reports First Quarter 2024 Financial Results
Freitag 3 Mai 2024 (3 Tage vor) • Business Wire

Amneal Announces U.S. FDA Approval of Over-the-Counter Naloxone Hydrochloride Nasal Spray for Emergency Treatment of an Opioid Overdose
Mittwoch 24 April 2024 (2 Wochen vor) • Business Wire

Amneal Launches PEMRYDI RTU®, the First Ready-to-Use Version of Important Oncology Injectable Medicine
Dienstag 16 April 2024 (3 Wochen vor) • Business Wire

Amneal to Report First Quarter 2024 Results on May 3, 2024
Mittwoch 10 April 2024 (4 Wochen vor) • Business Wire

Amneal to Ring the Nasdaq Closing Bell on April 2, 2024
Donnerstag 28 März 2024 (1 Monat vor) • Business Wire

Amneal Receives U.S. FDA Approval for Ciprofloxacin and Dexamethasone Otic Suspension
Montag 25 März 2024 (1 Monat vor) • Business Wire

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Freitag 22 März 2024 (1 Monat vor) • Edgar (US Regulatory)

Form DEF 14A - Other definitive proxy statements
Freitag 22 März 2024 (1 Monat vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Mittwoch 6 März 2024 (2 Monate vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Mittwoch 6 März 2024 (2 Monate vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Dienstag 5 März 2024 (2 Monate vor) • Edgar (US Regulatory)

Weitere Amneal Pharmaceuticals Holding Co News-Artikel

Deutsche Telekom

Euro vs Sterling

Financial Select Sector

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen